Original Article | ||||||||||||||||||||||||||||||
PNR. 2021; 12(1): 7-13 Comparative Benefits of Statins in Coronary Heart Disease Viktoriya Ermakova, Hizir Bataev, Natalya Semenenko. SUPPLEMENTARY FILES :
|
How to Cite this Article |
Pubmed Style Ermakova V, Bataev H, Semenenko N. Comparative Benefits of Statins in Coronary Heart Disease. PNR. 2021; 12(1): 7-13. doi:10.47750/pnr.2021.12.01.002 Web Style Ermakova V, Bataev H, Semenenko N. Comparative Benefits of Statins in Coronary Heart Disease. https://www.pnrjournal.com/?mno=68477 [Access: May 21, 2022]. doi:10.47750/pnr.2021.12.01.002 AMA (American Medical Association) Style Ermakova V, Bataev H, Semenenko N. Comparative Benefits of Statins in Coronary Heart Disease. PNR. 2021; 12(1): 7-13. doi:10.47750/pnr.2021.12.01.002 Vancouver/ICMJE Style Ermakova V, Bataev H, Semenenko N. Comparative Benefits of Statins in Coronary Heart Disease. PNR. (2021), [cited May 21, 2022]; 12(1): 7-13. doi:10.47750/pnr.2021.12.01.002 Harvard Style Ermakova, V., Bataev, . H. & Semenenko, . N. (2021) Comparative Benefits of Statins in Coronary Heart Disease. PNR, 12 (1), 7-13. doi:10.47750/pnr.2021.12.01.002 Turabian Style Ermakova, Viktoriya, Hizir Bataev, and Natalya Semenenko. 2021. Comparative Benefits of Statins in Coronary Heart Disease. Journal of Pharmaceutical Negative Results, 12 (1), 7-13. doi:10.47750/pnr.2021.12.01.002 Chicago Style Ermakova, Viktoriya, Hizir Bataev, and Natalya Semenenko. "Comparative Benefits of Statins in Coronary Heart Disease." Journal of Pharmaceutical Negative Results 12 (2021), 7-13. doi:10.47750/pnr.2021.12.01.002 MLA (The Modern Language Association) Style Ermakova, Viktoriya, Hizir Bataev, and Natalya Semenenko. "Comparative Benefits of Statins in Coronary Heart Disease." Journal of Pharmaceutical Negative Results 12.1 (2021), 7-13. Print. doi:10.47750/pnr.2021.12.01.002 APA (American Psychological Association) Style Ermakova, V., Bataev, . H. & Semenenko, . N. (2021) Comparative Benefits of Statins in Coronary Heart Disease. Journal of Pharmaceutical Negative Results, 12 (1), 7-13. doi:10.47750/pnr.2021.12.01.002 |